April 21 (Reuters) - Medlab Clinical Ltd (MDC) :
- MEDLAB CLINICAL LTD - MEDLAB EXTENDS NANOCELLE PLATFORM TO ANTI-MALARIA DRUG AS PART OF COVID-19 RELATED RESEARCH
News: MDC Medlab Clinical Says Co Extends Nanocelle Platform To Anti-Malaria Drug
Add to My Watchlist
What is My Watchlist?